REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 81 filers reported holding REPROS THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $281,000 | -14.1% | 32,700 | 0.0% | 0.00% | – |
| Q4 2014 | $327,000 | +0.9% | 32,700 | 0.0% | 0.00% | -100.0% |
| Q3 2014 | $324,000 | -42.8% | 32,700 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $566,000 | -2.6% | 32,700 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $581,000 | -3.0% | 32,700 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $599,000 | -32.4% | 32,700 | 0.0% | 0.00% | -50.0% |
| Q3 2013 | $886,000 | +73.4% | 32,700 | +22.5% | 0.00% | +100.0% |
| Q2 2013 | $511,000 | – | 26,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 978,800 | $1,292,000 | 0.33% |
| Allegis Investment Advisors, LLC | 344,487 | $455,000 | 0.14% |
| GENERAL AMERICAN INVESTORS CO INC | 589,768 | $778,000 | 0.08% |
| Acrospire Investment Management LLC | 23,177 | $31,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 268,130 | $354,000 | 0.01% |
| Alambic Investment Management, L.P. | 16,091 | $21,000 | 0.00% |
| OXFORD ASSET MANAGEMENT LLP | 51,359 | $68,000 | 0.00% |
| Renaissance Technologies | 716,413 | $946,000 | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 2,700 | $4,000 | 0.00% |
| Virtu KCG Holdings LLC | 45,144 | $60,000 | 0.00% |